Product
HEC585
2 clinical trials
2 indications
Indication
Idiopathic Pulmonary FibrosisClinical trial
A Phase IIb, Multi-center, Randomized, Double Blinded, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of HEC585 Tablets in Patients With Progressive Fibrosing Interstitial Lung DiseaseStatus: Recruiting, Estimated PCD: 2024-12-01